Nutra Pharma Corp. (NPHC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 3, 2026, 9:30 AM EST
Nutra Pharma Revenue
In the year 2024, Nutra Pharma had annual revenue of $392.15K, down -34.08%. Nutra Pharma had revenue of $121.53K in the quarter ending December 31, 2024, a decrease of -10.07%.
Revenue
392.15K
Revenue Growth
-34.08%
P/S Ratio
1.83
Revenue / Employee
65.36K
Employees
6
Market Cap
715.97K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 392.15K | -202.73K | -34.08% |
| Dec 31, 2023 | 594.88K | 156.61K | 35.73% |
| Dec 31, 2022 | 438.27K | 340.54K | 348.43% |
| Dec 31, 2021 | 97.74K | 45.84K | 88.32% |
| Dec 31, 2020 | 51.90K | -52.50K | -50.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tian'an Pharmaceutical | 10.65M |
| Target Group | 5.00M |
| Resonate Blends | 2.23M |
| Global Roundtable | 1.24M |
| TransGlobal Assets | 91.35K |
| Neutra | 66.07K |
| ViaDerma | 44.69K |
| Grapefruit USA | 34.85K |